Danielle Holley Whitley, MD - Medicare Emergency Medicine in Port Angeles, WA

Danielle Holley Whitley, MD is a medicare enrolled "Emergency Medicine" physician in Port Angeles, Washington. She graduated from medical school in 2011 and has 13 years of diverse experience with area of expertise as Emergency Medicine. She is a member of the group practice Highline Emergency Physicians Pllc, Northwest Hbp Medical Services Llc, Tri-cities Regional Emergency Physicians, Pc and her current practice location is 939 Caroline St, Port Angeles, Washington. You can reach out to her office (for appointments etc.) via phone at (360) 417-7000.

Danielle Holley Whitley is licensed to practice in Tennessee (license number 66121) and she also participates in the medicare program. She accepts medicare assignments (which means she accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and her NPI Number is 1275824435.

Contact Information

Danielle Holley Whitley, MD
939 Caroline St,
Port Angeles, WA 98362
(360) 417-7000
(360) 452-5772



Physician's Profile

Full NameDanielle Holley Whitley
GenderFemale
SpecialityEmergency Medicine
Experience13 Years
Location939 Caroline St, Port Angeles, Washington
Accepts Medicare AssignmentsYes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Danielle Holley Whitley graduated from medical school in 2011
  NPI Data:
  • NPI Number: 1275824435
  • Provider Enumeration Date: 04/22/2011
  • Last Update Date: 06/29/2023
  Medicare PECOS Information:
  • PECOS PAC ID: 0941443865
  • Enrollment ID: I20150620000024

Medical Identifiers

Medical identifiers for Danielle Holley Whitley such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1275824435NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
207P00000XEmergency Medicine 67174 (Arizona)Secondary
207P00000XEmergency Medicine C0755 (Kentucky)Secondary
207P00000XEmergency Medicine MD60476134 (Washington)Secondary
207P00000XEmergency Medicine 66121 (Tennessee)Primary

Medical Facilities Affiliation

Facility NameLocationFacility Type
Oro Valley HospitalOro valley, AZHospital
Highline Medical CenterBurien, WAHospital
Northwest Medical CenterTucson, AZHospital

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
Highline Emergency Physicians Pllc054743631318
Northwest Hbp Medical Services Llc8921356536117
Tri-cities Regional Emergency Physicians, Pc3678859477129

News Archive

Pharmasset reports SVR results from PSI-7977 phase 2b combination study on HCV genotype 1

Pharmasset, Inc., announced today sustained virologic response (SVR) results from its phase 2b PROTON study with PSI-7977 400 mg dosed once daily in combination with peginterferon alfa 2a and ribavirin (Peg-IFN/RBV) in subjects with hepatitis C virus (HCV) genotype 1 who have not been treated previously. 43 out of 44 (98%) evaluable subjects achieved an SVR12, defined as HCV RNA below the limit of detection (<15 IU/mL) 12 weeks after the completion of treatment.

Method based on genetic information predicts response to drugs in epileptic patients

Researchers affiliated with the University of Campinas in São Paulo State, Brazil, have shown that genetic information can be used to improve early prediction of the response to drugs in patients with mesial temporal lobe epilepsy (MTLE), one of the most severe forms of epilepsy.

BBC TV report profiles NW Bio's DCVax-L Phase III trial for GBM brain cancer

Northwest Biotherapeutics, Inc.("NW Bio"), a biotechnology company developing non-toxic DCVax® personalized immune therapies for solid tumor cancers, announced today that the British Broadcasting Company (BBC) TV network has broadcast a report profiling the first European patient in the Company's Phase III clinical trial of DCVax-L for Glioblastoma multiforme brain cancer (GBM), the most common and aggressive form of brain cancer.

2019 ASTMH Annual Meeting to focus on Ebola, monkey malaria, and other infectious diseases

This year's meeting will kick off with keynotes from two public health heroes who have pioneered a home-based approach to fighting infant mortality in India that's now being adopted in 10 countries.

Nearly one in four people with psoriasis may have undiagnosed psoriatic arthritis

If you have psoriasis or a family history of psoriasis and you are experiencing joint pain and swelling, you could have psoriatic arthritis, a serious disease that may lead to joint destruction and disability.

Read more Medical News

› Verified 6 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Danielle Holley Whitley allows following entities to bill medicare on her behalf.
Entity NameProsser Public Hospital District Of Benton County
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1306897681
PECOS PAC ID: 6709787872
Enrollment ID: O20040120000974

News Archive

Pharmasset reports SVR results from PSI-7977 phase 2b combination study on HCV genotype 1

Pharmasset, Inc., announced today sustained virologic response (SVR) results from its phase 2b PROTON study with PSI-7977 400 mg dosed once daily in combination with peginterferon alfa 2a and ribavirin (Peg-IFN/RBV) in subjects with hepatitis C virus (HCV) genotype 1 who have not been treated previously. 43 out of 44 (98%) evaluable subjects achieved an SVR12, defined as HCV RNA below the limit of detection (<15 IU/mL) 12 weeks after the completion of treatment.

Method based on genetic information predicts response to drugs in epileptic patients

Researchers affiliated with the University of Campinas in São Paulo State, Brazil, have shown that genetic information can be used to improve early prediction of the response to drugs in patients with mesial temporal lobe epilepsy (MTLE), one of the most severe forms of epilepsy.

BBC TV report profiles NW Bio's DCVax-L Phase III trial for GBM brain cancer

Northwest Biotherapeutics, Inc.("NW Bio"), a biotechnology company developing non-toxic DCVax® personalized immune therapies for solid tumor cancers, announced today that the British Broadcasting Company (BBC) TV network has broadcast a report profiling the first European patient in the Company's Phase III clinical trial of DCVax-L for Glioblastoma multiforme brain cancer (GBM), the most common and aggressive form of brain cancer.

2019 ASTMH Annual Meeting to focus on Ebola, monkey malaria, and other infectious diseases

This year's meeting will kick off with keynotes from two public health heroes who have pioneered a home-based approach to fighting infant mortality in India that's now being adopted in 10 countries.

Nearly one in four people with psoriasis may have undiagnosed psoriatic arthritis

If you have psoriasis or a family history of psoriasis and you are experiencing joint pain and swelling, you could have psoriatic arthritis, a serious disease that may lead to joint destruction and disability.

Read more Medical News

› Verified 6 days ago

Entity NameHighline Emergency Physicians Pllc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1669757290
PECOS PAC ID: 0547436313
Enrollment ID: O20111228000246

News Archive

Pharmasset reports SVR results from PSI-7977 phase 2b combination study on HCV genotype 1

Pharmasset, Inc., announced today sustained virologic response (SVR) results from its phase 2b PROTON study with PSI-7977 400 mg dosed once daily in combination with peginterferon alfa 2a and ribavirin (Peg-IFN/RBV) in subjects with hepatitis C virus (HCV) genotype 1 who have not been treated previously. 43 out of 44 (98%) evaluable subjects achieved an SVR12, defined as HCV RNA below the limit of detection (<15 IU/mL) 12 weeks after the completion of treatment.

Method based on genetic information predicts response to drugs in epileptic patients

Researchers affiliated with the University of Campinas in São Paulo State, Brazil, have shown that genetic information can be used to improve early prediction of the response to drugs in patients with mesial temporal lobe epilepsy (MTLE), one of the most severe forms of epilepsy.

BBC TV report profiles NW Bio's DCVax-L Phase III trial for GBM brain cancer

Northwest Biotherapeutics, Inc.("NW Bio"), a biotechnology company developing non-toxic DCVax® personalized immune therapies for solid tumor cancers, announced today that the British Broadcasting Company (BBC) TV network has broadcast a report profiling the first European patient in the Company's Phase III clinical trial of DCVax-L for Glioblastoma multiforme brain cancer (GBM), the most common and aggressive form of brain cancer.

2019 ASTMH Annual Meeting to focus on Ebola, monkey malaria, and other infectious diseases

This year's meeting will kick off with keynotes from two public health heroes who have pioneered a home-based approach to fighting infant mortality in India that's now being adopted in 10 countries.

Nearly one in four people with psoriasis may have undiagnosed psoriatic arthritis

If you have psoriasis or a family history of psoriasis and you are experiencing joint pain and swelling, you could have psoriatic arthritis, a serious disease that may lead to joint destruction and disability.

Read more Medical News

› Verified 6 days ago

Entity NameWashington Emergency Physician Partners Pllc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1346586351
PECOS PAC ID: 5092951814
Enrollment ID: O20130424000635

News Archive

Pharmasset reports SVR results from PSI-7977 phase 2b combination study on HCV genotype 1

Pharmasset, Inc., announced today sustained virologic response (SVR) results from its phase 2b PROTON study with PSI-7977 400 mg dosed once daily in combination with peginterferon alfa 2a and ribavirin (Peg-IFN/RBV) in subjects with hepatitis C virus (HCV) genotype 1 who have not been treated previously. 43 out of 44 (98%) evaluable subjects achieved an SVR12, defined as HCV RNA below the limit of detection (<15 IU/mL) 12 weeks after the completion of treatment.

Method based on genetic information predicts response to drugs in epileptic patients

Researchers affiliated with the University of Campinas in São Paulo State, Brazil, have shown that genetic information can be used to improve early prediction of the response to drugs in patients with mesial temporal lobe epilepsy (MTLE), one of the most severe forms of epilepsy.

BBC TV report profiles NW Bio's DCVax-L Phase III trial for GBM brain cancer

Northwest Biotherapeutics, Inc.("NW Bio"), a biotechnology company developing non-toxic DCVax® personalized immune therapies for solid tumor cancers, announced today that the British Broadcasting Company (BBC) TV network has broadcast a report profiling the first European patient in the Company's Phase III clinical trial of DCVax-L for Glioblastoma multiforme brain cancer (GBM), the most common and aggressive form of brain cancer.

2019 ASTMH Annual Meeting to focus on Ebola, monkey malaria, and other infectious diseases

This year's meeting will kick off with keynotes from two public health heroes who have pioneered a home-based approach to fighting infant mortality in India that's now being adopted in 10 countries.

Nearly one in four people with psoriasis may have undiagnosed psoriatic arthritis

If you have psoriasis or a family history of psoriasis and you are experiencing joint pain and swelling, you could have psoriatic arthritis, a serious disease that may lead to joint destruction and disability.

Read more Medical News

› Verified 6 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Danielle Holley Whitley is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Danielle Holley Whitley, MD
Po Box 850,
Port Angeles, WA 98362-0146

Ph: (360) 417-7000
Danielle Holley Whitley, MD
939 Caroline St,
Port Angeles, WA 98362

Ph: (360) 417-7000

News Archive

Pharmasset reports SVR results from PSI-7977 phase 2b combination study on HCV genotype 1

Pharmasset, Inc., announced today sustained virologic response (SVR) results from its phase 2b PROTON study with PSI-7977 400 mg dosed once daily in combination with peginterferon alfa 2a and ribavirin (Peg-IFN/RBV) in subjects with hepatitis C virus (HCV) genotype 1 who have not been treated previously. 43 out of 44 (98%) evaluable subjects achieved an SVR12, defined as HCV RNA below the limit of detection (<15 IU/mL) 12 weeks after the completion of treatment.

Method based on genetic information predicts response to drugs in epileptic patients

Researchers affiliated with the University of Campinas in São Paulo State, Brazil, have shown that genetic information can be used to improve early prediction of the response to drugs in patients with mesial temporal lobe epilepsy (MTLE), one of the most severe forms of epilepsy.

BBC TV report profiles NW Bio's DCVax-L Phase III trial for GBM brain cancer

Northwest Biotherapeutics, Inc.("NW Bio"), a biotechnology company developing non-toxic DCVax® personalized immune therapies for solid tumor cancers, announced today that the British Broadcasting Company (BBC) TV network has broadcast a report profiling the first European patient in the Company's Phase III clinical trial of DCVax-L for Glioblastoma multiforme brain cancer (GBM), the most common and aggressive form of brain cancer.

2019 ASTMH Annual Meeting to focus on Ebola, monkey malaria, and other infectious diseases

This year's meeting will kick off with keynotes from two public health heroes who have pioneered a home-based approach to fighting infant mortality in India that's now being adopted in 10 countries.

Nearly one in four people with psoriasis may have undiagnosed psoriatic arthritis

If you have psoriasis or a family history of psoriasis and you are experiencing joint pain and swelling, you could have psoriatic arthritis, a serious disease that may lead to joint destruction and disability.

Read more News

› Verified 6 days ago


Emergency Medicine Doctors in Port Angeles, WA

Ethan Mark Huckabee, DO
Emergency Medicine
Medicare: Accepting Medicare Assignments
Practice Location: 939 Caroline St, Port Angeles, WA 98362
Phone: 360-417-7000    Fax: 360-565-9241
Dr. Robert Lynn Lewis, M.D.
Emergency Medicine
Medicare: Not Enrolled in Medicare
Practice Location: 224 Scenic View Ln, Port Angeles, WA 98362
Phone: 360-417-5625    
Dr. Stephen Churchley, MD
Emergency Medicine
Medicare: Medicare Enrolled
Practice Location: 939 Caroline St, Port Angeles, WA 98362
Phone: 360-417-7000    
Dr. Alexa Ann Yager, D.O.
Emergency Medicine
Medicare: Medicare Enrolled
Practice Location: 939 Caroline St, Port Angeles, WA 98362
Phone: 360-417-7000    
Dr. John Whiting Sisson, MD
Emergency Medicine
Medicare: Accepting Medicare Assignments
Practice Location: 939 Caroline St, Port Angeles, WA 98362
Phone: 360-417-7000    Fax: 360-565-9241
Gregory J Harrah, MD
Emergency Medicine
Medicare: Not Enrolled in Medicare
Practice Location: 939 Caroline St, Port Angeles, WA 98362
Phone: 360-417-7724    Fax: 360-452-5772

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.